Richard L. Lindstrom

Lindstrom’s Perspective

Lindstrom's Perspective

Evidence seems to favor epithelium-on for future of cross-linking

Ocular Surgery News U.S. Edition, December 10, 2019
Richard L. Lindstrom, MD
The debate over epithelium-on vs. epithelium-off collagen cross-linking for keratoconus and post-corneal refractive surgery ectasia is, in my…
Lindstrom's Perspective

Customer service key to future practice success

Ocular Surgery News U.S. Edition, November 25, 2019
Richard L. Lindstrom, MD
After reading this issue’s cover story, I Googled “customer service books” and was directed to no less than 27 recent books focused…
Lindstrom's Perspective

Lifelong vision correction plan has value for all involved

Ocular Surgery News U.S. Edition, November 10, 2019
Richard L. Lindstrom, MD
I like the concept of lifetime management of refractive errors. I have a few thoughts as to how this might be accomplished. First, the patient has to…
Lindstrom's Perspective

Quality governance needed for today’s practices

Ocular Surgery News U.S. Edition, October 25, 2019
Richard L. Lindstrom, MD
Quality practice governance is critical to the long-term success of any practice. The corporate world has evolved to a structure that includes a…
Lindstrom's Perspective

Potential presbyopia treatments exciting, but regulatory and adoption barriers may be an issue

Ocular Surgery News U.S. Edition, October 10, 2019
Richard L. Lindstrom, MD
Presbyopia is very common, estimated to affect 120 million Americans and just more than 2 billion people globally. After decades of being limited to…
Lindstrom's Perspective

Focus on office-based practice can significantly increase revenue

Ocular Surgery News U.S. Edition, September 25, 2019
Richard L. Lindstrom, MD
I recently wrote a commentary on selective laser trabeculoplasty for glaucoma in the June 10, 2019, issue of Ocular Surgery News. In this…
Lindstrom's Perspective

Ophthalmologists who plan for reduced reimbursements will still find success

Ocular Surgery News U.S. Edition, September 10, 2019
Richard L. Lindstrom, MD
The unfortunate reality for the cataract surgeon today is that while reimbursement is going down per case, patient expectations are going up. To meet…
Lindstrom's Perspective

No easy answers to address drug shortages

Ocular Surgery News U.S. Edition, August 25, 2019
Richard L. Lindstrom, MD
According to the April 2, 2019, FDA drug shortages list, there were 270 current drugs in shortage across 26 therapeutic fields. The ophthalmic drugs…
Lindstrom's Perspective

Adjustable accommodating IOLs seem likely in near future

Ocular Surgery News U.S. Edition, August 10, 2019
Richard L. Lindstrom, MD
A number of years ago, David Chang, MD, asked me to write a chapter for a book he was editing on the future of ophthalmology, including cataract and…
Lindstrom's Perspective

Patient-centered advances enhance post-cataract surgery regimens

Ocular Surgery News U.S. Edition, July 25, 2019
Richard L. Lindstrom, MD
The overall global ophthalmic pharmaceuticals market was estimated to be approximately $30 billion per year by Market Scope in 2018, and it is…